Stryker Corporation (SYK) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Total Revenue Chart for Stryker Corporation
Stryker Corporation (SYK) revenue for FY2025 was USD 25.1B, a 11.2% change from FY2024. Stryker Corporation's revenue grew from USD 101.6M in 1985 to USD 25.1B in 2025 (24620.5% over 40 years). Earnings per share grew from USD 0.55 in 2000 to USD 8.49 in 2025 (1444.2%). Revenue compound annual growth rate: 5-year CAGR of 11.8%, 10-year CAGR of 9.7%, 20-year CAGR of 8.5%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $129.43B
- Implied Share Price
- $337.43
- Enterprise Value
- $140.74B
- Revenue (TTM)
- $25.84B
- EBITDA
- $7.38B
- Profit Margin
- 14.43%
- Trailing P/E
- 34.97
- Forward P/E
- 22.37
- Price/Book (MRQ)
- 5.37
- Price/Sales (TTM)
- 5.01
- EV/EBITDA
- 20.14
- EV/Revenue
- 5.43
- Dividend Yield
- 1.03%
- Book Value
- $59.94
- Free Cash Flow (FY2025)
- $4.28B
- Free Cash Flow Yield
- 3.31%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.